Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-02-21
2006-02-21
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S256000, C514S299000, C514S304000, C514S305000, C540S582000, C544S335000, C544S333000, C546S112000, C546S125000, C546S135000
Reexamination Certificate
active
07001900
ABSTRACT:
The invention provides compounds of Formula I:wherein Azabicyclo isW is a six-membered heterocyclic ring system having 1–2 nitrogen atoms or a 10-membered bicyclic-six-six-fused-ring system having up to two nitrogen atoms within either or both rings, provided that no nitrogen is at a bridge of the bicyclic-six-six-fused-ring system, and further having 1–2 substitutents independently selected from R3.These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals to treat diseases or conditions in which α7 is known to be involved.
REFERENCES:
patent: 3702324 (1972-11-01), Skinner
patent: 4089960 (1978-05-01), Gostell et al.
patent: 4093734 (1978-06-01), Kruger
patent: 4593034 (1986-06-01), Munson, Jr.
patent: 4605652 (1986-08-01), Welstead, Jr.
patent: 4612319 (1986-09-01), King
patent: 4657911 (1987-04-01), Imbert
patent: 4717563 (1988-01-01), Alphin
patent: 4721720 (1988-01-01), Woottton
patent: 4798829 (1989-01-01), King et al.
patent: 4803199 (1989-02-01), Donatsch
patent: 4820715 (1989-04-01), Monkovic
patent: 4835162 (1989-05-01), Abood
patent: 4870181 (1989-09-01), Lo
patent: 4877780 (1989-10-01), Vega-Noverola
patent: 4877794 (1989-10-01), Naylor
patent: 4908370 (1990-03-01), Naylor
patent: 4910193 (1990-03-01), Buchheit
patent: 4920219 (1990-04-01), Pelletier et al.
patent: 4920227 (1990-04-01), Pelletier et al.
patent: 4933445 (1990-06-01), Pelletier et al.
patent: 4985437 (1991-01-01), Tyers
patent: 5017580 (1991-05-01), Naylor
patent: 5025022 (1991-06-01), Naylor
patent: 5039680 (1991-08-01), Imperato
patent: 5057519 (1991-10-01), Suberg
patent: 5070095 (1991-12-01), Jagdmann, Jr.
patent: 5084460 (1992-01-01), Munson, Jr.
patent: 5106843 (1992-04-01), Ward
patent: 5175173 (1992-12-01), Sun
patent: 5206246 (1993-04-01), Langlois
patent: 5236931 (1993-08-01), Jagdmann
patent: 5237066 (1993-08-01), Dorme
patent: 5246941 (1993-09-01), Tyers
patent: 5273972 (1993-12-01), Jagdmann
patent: 5561149 (1996-10-01), Azria
patent: 5576434 (1996-11-01), Robinson
patent: 5723103 (1998-03-01), de Paulis et al.
patent: 5977144 (1999-11-01), Meyer et al.
patent: 6054464 (2000-04-01), Macor
patent: 6060473 (2000-05-01), Shen
patent: 6117889 (2000-09-01), Shen
patent: 6207679 (2001-03-01), Cuny et al.
patent: 6255490 (2001-07-01), Shen
patent: 0353371 (1988-08-01), None
patent: 0327335 (1989-02-01), None
patent: 0430190 (1990-11-01), None
patent: WO 91/17161 (1991-11-01), None
patent: WO 00/73431 (2000-12-01), None
patent: WO03/022856 (2003-03-01), None
Blum, E., XP000607037,Biorganic&Medicinal Chemistry Letters,Design and Synthesis of Novel Ligands for the 5-HT3 and the 5-HT4 Receptor, vol. 2, No. 5, pp. 461-466 (1992).
Gong, L. et al., XP009012605, Synthesis of the 3H-Labelled 5-HT, Antagonist (RS25259-1970 At High Specific Activity, pp. 425-433, (1996).
Kowalczyk, B.A., XP009012612, A Short Total Synthesis of Palonosetron Using Catalytic Hydrogenation, pp. 1439-1446 (1996).
Langlois, M., XP-001057029,Bioorganic&Medicinal Chemistry Letters,Derivatives of Quinuclidine as 5-HT3 Receptor Antagonists: Influence of an Additional Carbonyl Group on the Recongnition of Chirality by the Receptor, vol. 3, No. 8., pp. 1555-1558, (1993).
Orjales, Aurelio, et. al,Drug Design and Discovery,Syntheiss and 5-HT3 Receptor Affinity of New Quinolinecarboxylic Acid Derivatives, vol. 16, pp. 271-279, (2000).
Acker Brad A.
Groppi, Jr. Vincent E.
Jacobsen Eric Jon
Myers Jason K.
Piotrowski David W.
Ebel Eileen M.
Huang Evelyn Mei
Pfizer Inc.
Zelson Steve T.
LandOfFree
Azabicyclic compounds for the treatment of disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azabicyclic compounds for the treatment of disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azabicyclic compounds for the treatment of disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3642077